billHR6047Event Tuesday, June 2, 2026Analyzed

Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act of 2026

Bullish

Summary

HR 6047 expands veterans disability and survivor benefits but does not authorize or appropriate new spending for defense contractors. The bill is in early Senate stage with no direct market impact on publicly traded companies.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR 6047 expands veterans benefits but does not affect corporate earnings or sector dynamics.
  • 2.No publicly traded companies are directly impacted by this legislation.
  • 3.The bill is in early Senate stage; final passage likely but no market signal.

Market Implications

This bill has no market implications. It does not alter revenue, costs, or competitive dynamics for any publicly traded company. Retail investors should ignore this legislation for portfolio decisions.

Full Analysis

  1. HR 6047, the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act of 2026, was introduced in the House on November 17, 2025, passed the House on April 2, 2026, and was received in the Senate on June 2, 2026, where it was read twice and referred to the Committee on Veterans' Affairs. The bill is at an early stage in the Senate. 2) The bill does not authorize or appropriate any specific dollar amount. It mandates the VA to increase certain disability compensation rates and dependency and indemnity compensation (DIC) by formula-based adjustments tied to Social Security cost-of-living increases. No new funding is allocated; the costs would be absorbed within existing VA discretionary and mandatory spending. 3) The bill has no direct impact on defense contractors or any publicly traded company. The affected sector is strictly government veterans benefits administration. No tickers are structurally affected. 4) No real market data is provided. The bill's legislative path remains: Senate committee consideration, potential floor vote, and presidential action. 5) The bill is non-controversial and has bipartisan support (14 cosponsors, including Republicans and Democrats). Passage probability is high, but market impact is negligible.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.